B

BCAX

BCAX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio24% buys
BearishBullish
BCAX Live QuoteReal-time
$9.12
$8.79(-49.08%)1M
Day Range$9.04 – $9.55
Open$9.40
Previous Close$9.38
Volume844.7K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$605.45M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-3.36
Price to Book1.5
Dividend Yield0.65%
Beta (Volatility)-0.34
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $9.12 (5%)
Low: $7.87High: $30.99
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$32.17-78.6% upside

Insider Buys

1

$4.80M

Insider Sales

44

$14.91M

Total Volume

$19.71M

80 transactions

Net Activity

$10.11M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 76% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •High accumulation: total purchase value exceeds $1M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale+OE Insiders

0 buys35 sells

$2176.80B total

R
2

Ra Capital Management, L.P.

Dir, 10%

1 buys0 sells

$4.80M total

C
3

Cohlhepp Ryan

Pres, COO, Interim CEO

0 buys14 sells

$4.60M total

M
4

Mazumdar Claire

CEO

0 buys10 sells

$4.06M total

H
5

Hyep Ivan

CFO

0 buys11 sells

$3.24M total

Trading History
BCAX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 8, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell181.6K$-17500.00$0

Sep 8, 2026

2 months ago

Cohlhepp Ryan

Pres, COO, Interim CEO

CEO
Sell17.5K$22.90$401K

Aug 10, 2026

3 months ago

Mazumdar Claire

CEO

CEO
Sell10.0K$27.98$280K

Aug 10, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell129.9K$-12500.00$0

Aug 10, 2026

3 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell18.8K$27.98$525K

Aug 10, 2026

3 months ago

Hyep Ivan

CFO

CFO
Sell12.5K$27.97$350K

Jul 10, 2026

4 months ago

Mazumdar Claire

CEO

CEO
Sell10.0K$28.42$284K

Jul 10, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell362.2K$-10000.00$0

Jul 8, 2026

4 months ago

Hyep Ivan

CFO

CFO
Sell28.0K$28.85$808K

Jul 8, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell181.6K$-28750.00$0

Jul 8, 2026

4 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell28.8K$28.98$833K

May 21, 2026

6 months ago

Hyep Ivan

CFO

CFO
Sell9.2K$20.42$188K

May 21, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell145.4K$-9200.00$0

May 18, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell362.2K$-15000.00$0

May 18, 2026

6 months ago

Mazumdar Claire

CEO

CEO
Sell15.0K$20.04$301K

May 15, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell191.6K$-12500.00$0

May 15, 2026

6 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell12.5K$20.29$254K

Apr 27, 2026

6 months ago

Raben David

Chief Medical Officer

C-Level
Sell5.5K$22.88$126K

Apr 27, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell55.3K$-5500.00$0

Apr 21, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell145.4K$-9200.00$0

Apr 21, 2026

7 months ago

Hyep Ivan

CFO

CFO
Sell9.2K$23.00$212K

Apr 20, 2026

7 months ago

Mazumdar Claire

CEO

CEO
Sell15.0K$23.61$354K

Apr 20, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell362.2K$-15000.00$0

Apr 15, 2026

7 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell196.1K$-12500.00$0

Apr 15, 2026

7 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell12.5K$23.01$288K

Mar 25, 2026

8 months ago

Raben David

Chief Medical Officer

C-Level
Sell5.5K$18.95$104K

Mar 25, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell55.3K$-5500.00$0

Mar 23, 2026

8 months ago

Hyep Ivan

CFO

CFO
Sell9.2K$18.52$170K

Mar 23, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell145.4K$-9200.00$0

Mar 18, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell339.4K$-15000.00$0

Mar 18, 2026

8 months ago

Mazumdar Claire

CEO

CEO
Sell15.0K$18.82$282K

Mar 16, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell200.6K$-12500.00$0

Mar 16, 2026

8 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell12.5K$19.66$246K

Mar 9, 2026

8 months ago

Mazumdar Claire

CEO

CEO
Sell36.8K$19.17$705K

Mar 9, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell339.4K$-36766.00$0

Mar 4, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell339.4K$-8234.00$0

Mar 4, 2026

8 months ago

Mazumdar Claire

CEO

CEO
Sell8.2K$18.74$154K

Mar 3, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell205.1K$-17392.00$0

Mar 3, 2026

8 months ago

Hyep Ivan

CFO

CFO
Sell16.5K$18.22$301K

Mar 3, 2026

8 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell17.4K$18.16$316K

Mar 3, 2026

8 months ago

Raben David

Chief Medical Officer

C-Level
Sell16.5K$18.52$306K

Feb 26, 2026

8 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell7.26M$300000.00$2176.80B

Feb 26, 2026

8 months ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy300.0K$16.00$4.80M

Feb 25, 2026

8 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell3.6K$18.04$66K

Feb 25, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell209.6K$-3631.00$0

Jan 22, 2026

10 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell3.8K$18.10$69K

Jan 22, 2026

10 months ago

Hyep Ivan

CFO

CFO
Sell1.9K$18.15$34K

Jan 22, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell210.2K$-3828.00$0

Jan 15, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell214.0K$-149.00$0

Jan 15, 2026

10 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell149$18.02$3K

Dec 22, 2025

11 months ago

Hyep Ivan

CFO

CFO
Sell9.2K$18.31$168K

Dec 22, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell145.4K$-9200.00$0

Dec 15, 2025

11 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell189.1K$-12500.00$0

Dec 15, 2025

11 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell12.5K$18.68$234K

Nov 21, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell145.4K$-18400.00$0

Nov 21, 2025

12 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell12.5K$18.05$226K

Nov 24, 2025

12 months ago

Mazumdar Claire

CEO

CEO
Sell41.2K$18.86$776K

Nov 24, 2025

12 months ago

Raben David

Chief Medical Officer

C-Level
Sell11.0K$18.65$205K

Nov 24, 2025

12 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell309.9K$-41163.00$0

Nov 21, 2025

12 months ago

Hyep Ivan

CFO

CFO
Sell18.4K$18.54$341K

Oct 16, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell309.9K$-24103.00$0

Oct 16, 2025

13 months ago

Mazumdar Claire

CEO

CEO
Sell24.1K$18.83$454K

Oct 15, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell198.1K$-12500.00$0

Oct 15, 2025

13 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell12.5K$18.16$227K

Oct 13, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell309.9K$-24734.00$0

Oct 13, 2025

13 months ago

Mazumdar Claire

CEO

CEO
Sell24.7K$18.88$467K

Oct 9, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell35.5K$-22000.00$0

Oct 9, 2025

13 months ago

Raben David

Chief Medical Officer

C-Level
Sell22.0K$18.45$406K

Oct 9, 2025

13 months ago

Hyep Ivan

CFO

CFO
Sell6.4K$18.23$117K

Oct 6, 2025

13 months ago

Hyep Ivan

CFO

CFO
Sell30.4K$18.21$553K

Oct 6, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell145.4K$-30385.00$0

Oct 6, 2025

13 months ago

Cohlhepp Ryan

Pres, COO

COO
Sell50.5K$18.06$912K

Sep 29, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-33807.00$0

Sep 29, 2025

13 months ago

Meisner Lara

GC

General Counsel
Sell33.8K$14.75$499K

Sep 15, 2025

14 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-15829.00$0

Sep 15, 2025

14 months ago

Meisner Lara

GC

General Counsel
Sell15.8K$11.49$182K

Jun 16, 2025

17 months ago

Meisner Lara

GC

General Counsel
Sell15.8K$10.43$165K

Jun 16, 2025

17 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-15829.00$0

Mar 14, 2025

20 months ago

Meisner Lara

GC

General Counsel
Sell79.1K$12.90$1.02M

Mar 14, 2025

20 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-79146.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
BCAX Buy Conviction24%
Industry Rank#0 of 570
Volume Contribution0.1%
Total Industry Activity$16.52B

BCAX has an insider buy conviction of 24%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for BCAX

Over the last 90 days, corporate insiders at BCAX (BCAX) engaged in a total of 80 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 44 were sales. The total volume of insider trading reached $19.71M.

The net insider activity for BCAX shows a net selling bias of $10.11M. This activity represents a 24% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 7.26M shares valued at $2176.80B on Feb 26, 2026.

Live Market News & Developments
Aggregated real-time headlines for BCAX (BCAX)
6 updates

Bicara Therapeutics (BCAX) Stock Gets Fair Value Trim As Analysts Split On Ficera

Yahoo Finance7d ago

BCAX Stock Price and Chart — NASDAQ:BCAX

TradingView23d ago

$BCAX stock is down 35% today. Here's what we see in our data.

Quiver Quantitative23d ago

Behavioral Patterns of BCAX and Institutional Flows

Stock Traders Daily3d ago

BCAX - Bicara Therapeutics Inc Stock Price and Quote

Finviz177d ago

Bicara Therapeutics (BCAX) Stock May Look Overvalued On Book Value

Yahoo Finance41d ago

FAQs About BCAX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for BCAX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for BCAX is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 1 purchases and 44 sales by company executives over the last 90 days.

The CEO Conviction Index for BCAX is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.